Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05944237
What this trial is testing

HTL0039732 in Participants With Advanced Solid Tumours

Who this might be right for
NeoplasmsProstatic Neoplasms, Castration-ResistantStomach Neoplasms+11 more
Cancer Research UK 150
Early research (Phase 1)Study completedNCT00379639
What this trial is testing

Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors

Who this might be right for
Pancreatic Cancer
Celgene 36
Testing effectiveness (Phase 2)Study completedNCT05185947
What this trial is testing

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

Who this might be right for
Gynecologic CancerGynecologic NeoplasmsPeritoneal Carcinomatosis+9 more
National Cancer Institute (NCI) 21
Not applicableStudy completedNCT04369339
What this trial is testing

Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology

Who this might be right for
Human Papillomavirus Infection
Bezmialem Vakif University 185
Early research (Phase 1)UnknownNCT04727164
What this trial is testing

Study Investigating Safety,Tolerability,Pharmacokinetics and Antitumor Activities of HBM4003 Combine With Toripalimab

Who this might be right for
Solid Tumors
Harbour BioMed (Guangzhou) Co. Ltd. 61
Testing effectiveness (Phase 2)Looking for participantsNCT05098132
What this trial is testing

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerUntreated Advanced NSCLC+1 more
Synthekine 364
Testing effectiveness (Phase 2)Ended earlyNCT04387071
What this trial is testing

CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8+1 more
University of Southern California 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05081609
What this trial is testing

Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Advanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+10 more
Ascendis Pharma Oncology Division A/S 320
Early research (Phase 1)Ended earlyNCT00064636
What this trial is testing

Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Who this might be right for
Advanced Non-Small Cell Lung CancerOther Solid Tumors
Millennium Pharmaceuticals, Inc. 46
Early research (Phase 1)Study completedNCT01665183
What this trial is testing

Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma

Who this might be right for
Cutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid Tumors
Polaris Group 8
Testing effectiveness (Phase 2)Looking for participantsNCT07669779
What this trial is testing

A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non Small Cell Lung Cancer (NSCLC)
Akeso 348
Early research (Phase 1)Study completedNCT01587703
What this trial is testing

Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers

Who this might be right for
Carcinoma, Midline
GlaxoSmithKline 196
Very early researchEnded earlyNCT00253461
What this trial is testing

11C Topotecan PET Imaging

Who this might be right for
Lung CancerMetastatic CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center 7
Early research (Phase 1)Study completedNCT00003750
What this trial is testing

Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors

Who this might be right for
Melanoma (Skin)NeuroblastomaSarcoma+1 more
Children's Oncology Group 28
Not applicableStudy completedNCT01229124
What this trial is testing

RNA Biomarkers in Tissue Samples From Infants With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 20
Testing effectiveness (Phase 2)Looking for participantsNCT06512051
What this trial is testing

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Advanced or Metastatic Non-small Cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 248
Not applicableStudy completedNCT02364388
What this trial is testing

IMAging With Opto-acoustics to downgradE BI-RADS claSsificaTion Relative tO Other Diagnostic Methodologies (MAESTRO)

Who this might be right for
Breast Cancer
Seno Medical Instruments Inc. 217
Testing effectiveness (Phase 2)Looking for participantsNCT07123454
What this trial is testing

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Non-Hodgkin Lymphoma
AstraZeneca 91
Not applicableStudy completedNCT01438138
What this trial is testing

Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 98
Not applicableStudy completedNCT03305380
What this trial is testing

Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour Growth

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Maastricht Radiation Oncology 637
Next Page